Korean J Dermatol.
1998 Apr;36(2):326-330.
Stevens-Johnson Syndrome as a Side Effect of Topical Immunotherapy with Diphenylcyclopropenone
Abstract
- Topical immunotherapy with diphenylcyclopropenone(DPCP) has been used for the treatment of alopecia areata. Due to the therapeutic principle of producing a contact eczema, itching, erythema and scaling are inevitable or even desired side effects. However, erythema multiforme-like reactions following topical DPCP treatment have been rarely reported with an estimated incidence of 1.2%. We present herein a case of Stevens-Johnson syndrome, the severe form of erythema multiforme as a side effect of topical DPCP. A 57-year old male patient visited us for the treatment of alopecia totalis. After sensitization with 0.2% DPCP in acetone, we applied DPCP on the scalp once a week for three weeks. Following the 3rd challenge of DPCP, iris-shaped lesions, erosions, vesicles, and bullae developed with fever. Also, he had vesicles and erosions in the oral cavity. The patient was treated with systemic antibiotics, steroids, and antihistamines. The cutaneous lesions were cleared with hyperpigmentation, and pronounced hair regrowth was observed.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical Study of Stevens-Johnson Syndrome
- A Case of Stevens-Johnson Syndrome in a Hypoxic Brain Injury Patient Treated with Carbamazepine
- The Effect of Diphenylcyclopropenone Immunotherapy on Molluscum Contagiosum
- A Case of Secondary Milia Associated with Stevens-Johnson Syndrome
- Five Cases of Stevens-Johnson Syndrome May Be Associated with Methazolamide Treatment
